HomeAIM • NYSEAMERICAN
add
AIM ImmunoTech Inc
$0.23
Pre-market:(3.11%)+0.0070
$0.23
Sarado: Nob 27, 6:50:55 AM GMT-5 · USD · NYSEAMERICAN · Disclaimer
Nakaraang pagsara
$0.21
Sakop ng araw
$0.21 - $0.23
Sakop ng taon
$0.16 - $0.62
Market cap
14.34M USD
Average na Volume
542.70K
P/E ratio
-
Dividend yield
-
Mga balita tungkol sa merkado
Mga Financial
Income Statement
Kita
Net na kita
| (USD) | Set 2024info | Y/Y na pagbabago |
|---|---|---|
Kita | 35.00K | -23.91% |
Gastos sa pagpapatakbo | 4.52M | -44.74% |
Net na kita | -3.70M | 52.66% |
Net profit margin | -10.57K | 37.78% |
Kita sa bawat share | -0.07 | 57.39% |
EBITDA | -4.43M | 45.38% |
Aktuwal na % ng binabayarang buwis | — | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (USD) | Set 2024info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 7.20M | -67.89% |
Kabuuang asset | 13.59M | -51.23% |
Kabuuang sagutin | 10.68M | 103.00% |
Kabuuang equity | 2.91M | — |
Natitirang share | 63.71M | — |
Presyo para makapag-book | 4.26 | — |
Return on assets | -76.60% | — |
Return on capital | -142.29% | — |
Cash Flow
Net change in cash
| (USD) | Set 2024info | Y/Y na pagbabago |
|---|---|---|
Net na kita | -3.70M | 52.66% |
Cash mula sa mga operasyon | -3.11M | 45.16% |
Cash mula sa pag-invest | 334.00K | 199.40% |
Cash mula sa financing | 137.00K | -41.20% |
Net change in cash | -2.64M | 54.30% |
Malayang cash flow | -2.11M | 34.80% |
Tungkol
AIM ImmunoTech Inc., formerly known as Hemispherx Biopharma Inc., is a biopharmaceutical company based in Ocala, Florida that is focused on the research and development of therapeutics to treat multiple types of cancers, various viruses and immune-deficiency disorders. Founded in 1990, the company has twenty-three employees.
The company has created an immunomodulatory double stranded RNA drug called Ampligen.
It is also developing Ampligen to use as a treatment for multiple cancer tumor types, COVID-19 and chronic fatigue syndrome. Wikipedia
Itinatag
1966
Headquarters
Website
Mga Empleyado
27
